Formulation of lyophilized cold kit for instant preparation of 99mTc-glucarate and its scintigraphic evaluation in experimental models of infarction

Indian Journal of Pharmacology

Volumn 35, Issue 1, 2003, Pages 13-20

  Babbar, A K ^a   Sharma, R K ^a  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

Coronary artery disease; Infarction imaging; Myocardial scintigraphy

Indexed keywords

PERTECHNETIC ACID TC 99M; RADIOPHARMACEUTICAL AGENT; SACCHARIC ACID TC 99M; TRACER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; COLD; DIAGNOSTIC KIT; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG FORMULATION; DRUG PURITY; FREEZE DRYING; HEART; HEART INFARCTION; HYDROLYSIS; IN VITRO STUDY; IN VIVO STUDY; INTESTINE; ISCHEMIA; ISOTOPE LABELING; KIDNEY; LIVER; LUNG; NECROSIS; NONHUMAN; PLASMA CLEARANCE; PROTEIN BINDING; RABBIT; RADIOACTIVITY; RADIOCHEMISTRY; RAT; SCINTIGRAPHY; SKELETAL MUSCLE; STOMACH; THIN LAYER CHROMATOGRAPHY; TISSUE DISTRIBUTION; TISSUE INJURY;

EID: 0037317288     PISSN: 02537613     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Reddy KS. Cardiovascular diseases in India. Wld Hlth Quart 1993;46:101-7.
2. Willerson JT. Detection of acute myocardial infarctions by infarct-avid imaging. J Nucl Med 1991;32:269-71.
3. Strauss HW, Narula J, Khaw BA. Acute myocardial infarction imaging with technetium-99m and indium-111 antimyocin Fab. In: Khaw BA, Narula J, Strauss HW, eds Monoclonal Antibodies in Cardiovascular Diseases. Philadelphia, Pa: Lea & Febiger; 1994. p. 30-42.
4. Ohtani H, Callahan RJ, Khaw BA, Fishman AJ, Wilkinson RA, Strauss HW et al. Comparison of technetium-99m-glucarate and thallium-201 for the identification of acute myocardial infarction in rats. J Nucl Med 1992;33:1988-93.
5. Pak KY, Nedelman MA, Kanke M, Khaw BA, Mattis JA, Strauss HW, et al. An instant kit method for labelling antimyosin Fab′ with technetium-99m: Evaluation in an experimental myocardial infarct model. J Nucl Med 1992;33:144-9.
6. Levine MG, McGill CC, Ahlberg AW, White MP, Giri S, Shareef B, et al. Functional assessment with electrocardiographic gated single-photon emission computed tomography improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization. Am J Cardiol 1999;83:1-5.
7. Taileffer R, Lambert R, Essiambre R, Phaneuf DC, Leveille J. Comparison between thallium-201, technetium-99m-sestamibi and technetium-99m-teboroxime planar myocardial perfusion imaging in detection of coronary artery disease. J Nucl Med 1992;33:1091-8.
8. Matsunari I, Fujino S, Taki J, Semma J, Aoyama T, Wakasugi T, et al. Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease. J Nucl Med 1995;36:1961-7.
9. Nunn AD. Radiopharmaceuticals for imaging myocardial perfusion. Semin Nucl Med 1990;20:111-8.
10. 99mTc labelled acetylated-LDL for scintigraphy of LDL-scavenger receptor sites of macrophageal origin. Nucl Med Biol 2001;28:235-41.
11. Khaw BA, Nakazawa A, O'Donnell SM, Pak KY, Narula J. Avidity of technetium-99m-glucarate for the necrotic myocardium: In vivo and in vitro assessment. J Nucl Cardiol 1997;4:283-90.
12. Yaoita H, Uehara T, Brownell AL, Rabito CA, Ahmed M, Khaw BA, et al. Localization of technetium-99m-glucarate in zones of acute cerebral injury. J Nucl Med 1991;32:272-8.
13. Petrov AD, Narula J, Nakazawa A, Pak KY, Khaw BA. Targeting human breast tumour in xenografted SCID mice with Tc-99m-glucarate. Nucl Med Commun 1997;18:241-251.
14. Adler N, Camin LL, Shulkin P. Rat model for acute myocardial infarction: Application to technetium labelled glucoheptonate, tetracycline and polyphosphate. J Nucl Med 1976;17:203-7.
15. Goldstein JL and Brown MS. The low-density lipoproteins pathway and its relation to atherosclerosis. Ann Rev Biochem 1977;46:897-930.
16. Yaoita H, Fischman AJ, Wilkinson R, Khaw BA, Juweid M, Strauss HW, et al. Distribution of deoxyglucose and technetium-99m-glucarate in the acutely ischemic myocardium. J Nucl Med 1993;34:1303-8.
17. Wiersema AM, Oyen WJ, Dirksen R, Verhofstad AA, Corstens FH, Van Der Vliet JA, et al. Early assessment of skeletal muscle damage after ischaemia-reperfusion injury using Tc-99m-glucarate. Cardiovasc Surg 2000;8:186-91.
18. Babbar AK, Singh T, Chauhan UPS. A critical evaluation of radiolabelling of glucaric acid with Tc-99m as a potential myocardial infarct imaging radiopharmaceutical. Indian J Nucl Med 1996;11:98-102.
19. Ballinger JR, Proulx A, Ruddy TD. Stable kit formation of technetium-99m-glucarate. Appld Radiat Isot 1991;42:405-6.
20. Narula J, Petrov A, Pak KY, Lister BC, Khaw BA. Very early noninvasive detection of acute experimental nonreperfused myocardial infarction with 99mTc-labelled glucarate. Circulation 1997;95:1577-84.
21. Orlandi C, Crane PD, Edwards DS, Platts SH, Barnard L, Lazewatsky J, et al. Early scintigraphic detection of experimental myocardial infarction in dogs with technetium-99m-glucaric acid. J Nucl Med 1991;32:263-8.
22. Kashyap R, Babbar AK, Mondal A, Swrup K, Chauhan UPS. Tc-99m-glucaric acid imaging: A new way to assess avascular necrosis of femoral head. Eur J Nucl Med 1998;25:901.
23. Das DK, Maulik N. Molecular basis of adapted heart. In: Gupta SK, editor. Pharmacology and Therapeutics in the New Millennium. New Delhi: Narosa Publishing House; 2001. p. 138-65.